Abstract
* Currently there is significant confusion and polarisation about prostate cancer screening for both patients and physicians alike. * We propose a risk-adjusted testing programme, which would lead to fewer patients who need to be tested and treated to save a life and also eliminate inappropriate prostate-specific antigen testing in the elderly and patients with severe co-morbidities where there is no clear benefit.
Original language | English |
---|---|
Pages (from-to) | 30 - 34 |
Number of pages | 5 |
Journal | BJU International |
Volume | 110 |
Issue number | Suppl S4 |
DOIs | |
Publication status | Published - 2012 |